Zvi Shmuel Ben - 30 Jun 2022 Form 3 Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Role
Director
Signature
/s/ Eyal Rubin, POA
Issuer symbol
PLX
Transactions as of
30 Jun 2022
Net transactions value
$0
Form type
3
Filing time
05 Jul 2022, 16:30:59 UTC
Next filing
09 Sep 2022

No securities are beneficially owned.